Progressive cerebral deposition of amyloid beta occurs in Alzheimers disease and during the aging of certain mammals (human, monkey, dog, bear, cow, cat) but not others (rat, mouse). It is possibly due to different amino acid sequences at positions 5, 10 and 13. To address this issue, we performed series of 100 ns long trajectories (each trajectory was run twice with different initial velocity distribution) on amyloid beta (1-42) with the human and rat amino acid sequence in three different environments: water with only counter ions, water with NaCl at a concentration of 0.15 M as a model of intracellular Na(+) concentration at steady state, and water with NaCl at a concentration of 0.30 M as a model of intracellular Na(+) concentration under stimulated conditions. We analyzed secondary structure stability, internal hydrogen bonds, and residual fluctuation. It was observed that the change in ionic strength affects the stability of internal hydrogen bonds. Increasing the ionic strength increases atomic fluctuation in the hydrophobic core of the human amyloid, and decreases the atomic fluctuation in the case of rat amyloid. The secondary structure analyses show a stable α-helix part between residues 10 and 20. However, C-terminus of investigated amyloids is much more flexible showing no stable secondary structure elements. Increasing ionic strength of the solvent leads to decreasing stability of the secondary structural elements. The difference in conformational behavior of the three amino acids at position 5, 10 and 13 for human and rat amyloids significantly changes the conformational behavior of the whole peptide.

Central European Institute of Technology Masaryk University Brno Czech Republic

Zobrazit více v PubMed

Ausiello DA, Benos DJ, Abboud F, Koopman W, Epstein P (2004) Alzheimer disease: mechanistic understanding predicts novel therapies. Ann. Intern. Med. 140: 627–638. PubMed

Braak H, Braak E (1994) Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder. Neurobiol. Aging 15: 355–356. PubMed

Wirths O, Multhaup G, Bayer TA (2004) A modified β-amyloid hypothesis: intraneuronal accumulation of the β-amyloid peptide – the first step of a fatal cascade. J. Neurochem. 91: 513–520. PubMed

Rauk A (2008) Why is the amyloid beta peptide of Alzheimer's disease neurotoxic? Dalton Trans: 1273–1282. PubMed

Tjernberg LO, Näslund J, Lindqvist F, Johansson J, Karlström AR, et al. (1996) Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand. J. Biol. Chem. 271: 8545–8548. PubMed

Tjernberg LO, Lilliehöök C, Callaway DJE, Näslund J, Hahne S, et al. (1997) Controlling Amyloid β-Peptide Fibril Formation with Protease-stable Ligands. J. Biol. Chem. 272: 12601–12605. PubMed

Yao Z-X, Papadopoulos V (2002) Function of ß-amyloid in cholesterol transport: a lead to neurotoxicity. FASEB J. 16: 1677–1679. PubMed

Sadowski MJ, Pankiewicz J, Scholtzova H, Mehta PD, Prelli F, et al. (2006) Blocking the apolipoprotein E/amyloid-β interaction as a potential therapeutic approach for Alzheimer's disease. P NAS 103: 18787–18792. PubMed PMC

Wang H, Lee DHS, Davis CB, Shank RP (2000) Amyloid Peptide Aβ1-42 Binds Selectively and with Picomolar Affinity to α7 Nicotinic Acetylcholine Receptors. J. Neurochem. 75: 1155–1161. PubMed

Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, et al. (2004) ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease. Science 304: 448–452. PubMed

Milton NG (1999) Amyloid-beta binds catalase with high affinity and inhibits hydrogen peroxide breakdown. Biochem. J. 344: 293–296. PubMed PMC

Milton NG, Mayor NP, Rawlinson J (2001) Identification of amyloid-[beta] binding sites using an antisense peptide approach. Neuroreport 12: 2561–2566. PubMed

Coles M, Bicknell W, Watson AA, Fairlie DP, Craik DJ (1998) Solution Structure of Amyloid β-Peptide(1−40) in a Water−Micelle Environment. Is the Membrane-Spanning Domain Where We Think It Is? Biochem. 37: 11064–11077. PubMed

Sticht H, Bayer P, Willbold D, Dames S, Hilbich C, et al. (1995) Structure of Amyloid A4-(1–40)-Peptide of Alzheimer's Disease. Eur. J. Biochem. 233: 293–298. PubMed

Schladitz C, Vieira EP, Hermel H, Möhwald H (1999) Amyloid–β-Sheet Formation at the Air-Water Interface. Biophys. J. 77: 3305–3310. PubMed PMC

Curtain CC, Ali F, Volitakis I, Cherny RA, Norton RS, et al. (2001) Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits. J. Biol. Chem. 276: 20466–20473. PubMed

Mastrangelo IA, Ahmed M, Sato T, Liu W, Wang C, et al. (2006) High-resolution Atomic Force Microscopy of Soluble Aβ42 Oligomers. J. Mol. Biol. 358: 106–119. PubMed

Losic D, Martin LL, Mechler A, Aguilar M-I, Small DH (2006) High resolution scanning tunnelling microscopy of the β-amyloid protein (Aβ1–40) of Alzheimer's disease suggests a novel mechanism of oligomer assembly. J. Struct. Biol. 155: 104–110. PubMed

Dominy BN, Perl D, Schmid FX, Brooks CL (2002) The effects of ionic strength on protein stability: the cold shock protein family. J. Mol. Biol. 319: 541–554. PubMed

Otzen DE (2002) Protein unfolding in detergents: effect of micelle structure, ionic strength, pH, and temperature. Biophys. J. 83: 2219–2230. PubMed PMC

Stine WB, Dahlgren KN, Krafft GA, LaDu MJ (2003) In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis. J. Biol.l Chem. 278: 11612–11622. PubMed

Podlisny MB, Tolan DR, Selkoe DJ (1991) Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. Am. J. Pathol. 138: 1423–1435. PubMed PMC

Pawlik M, Fuchs E, Walker LC, Levy E (1999) Primate-like amyloid-β sequence but no cerebral amyloidosis in aged tree shrews. Neurobiol. Aging 20: 47–51. PubMed

Tomaselli S, Esposito V, Vangone P, Van Nuland NAJ, Bonvin AMJJ, et al. (2006) The α-to-β Conformational Transition of Alzheimer's Aβ-(1–42) Peptide in Aqueous Media is Reversible: A Step by Step Conformational Analysis Suggests the Location of β Conformation Seeding. Chem. Bio. Chem. 7: 257–267. PubMed

Prokop M, Adam J, Kříž Z, Wimmerová M, Koča J (2008) TRITON: a graphical tool for ligand-binding protein engineering. Bioinformatics 24: 1955–1956. PubMed PMC

Sali A, Blundell TL (1993) Comparative Protein Modelling by Satisfaction of Spatial Restraints. J. Mol. Biol. 234: 779–815. PubMed

Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79: 926–929.

Grubmuller H (1996) Solvate: a program to create atomic solvent models.

Case DA, Darden TA, Cheatham III TE, Simmerling CL, Wang J, et al.. (2011) AMBER. Available: http://ambermd.org/.

Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, et al. (2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24: 1999–2012. PubMed

Florová P, Sklenovský P, Banáš P, Otyepka M (2010) Explicit Water Models Affect the Specific Solvation and Dynamics of Unfolded Peptides While the Conformational Behavior and Flexibility of Folded Peptides Remain Intact. J. Chem. Theor. Comput. 6: 3569–3579. PubMed

Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, et al. (2006) Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Struct. Func. Bioinform. 65: 712–725. PubMed PMC

Sklenovský P, Banáš P, Otyepka M (2008) Two C-terminal ankyrin repeats form the minimal stable unit of the ankyrin repeat protein p18INK4c. J. Mol. Mod. 14: 747–759. PubMed

Lepšík M, Kříž Z, Havlas Z (2004) Efficiency of a second-generation HIV-1 protease inhibitor studied by molecular dynamics and absolute binding free energy calculations. Proteins: Struct. Func. Bioinform. 57: 279–293. PubMed

Otyepka M, Bártová I, Kříž Z, Koča J (2006) Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics. J. Biol. Chem. 281: 7271–7281. PubMed

Ryckaert J, Ciccotti G, Berendsen H (1977) Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23: 327–341.

Berendsen HJC, Postma JPM, Van Gunsteren WF, DiNola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81: 3684–3690.

Kabsch W, Sander C (1983) Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22: 2577–2637. PubMed

Shao J, Tanner SW, Thompson N, Cheatham TE (2007) Clustering Molecular Dynamics Trajectories: 1. Characterizing the Performance of Different Clustering Algorithms. J. Chem. Theor. Comput. 3: 2312–2334. PubMed

Marshall KE, Morris KL, Charlton D, O'Reilly N, Lewis L, et al. (2011) Hydrophobic, aromatic, and electrostatic interactions play a central role in amyloid fibril formation and stability. Biochem. 50: 2061–2071. PubMed

Urbanc B, Cruz L, Yun S, Buldyrev SV, Bitan G, et al. (2004) In silico study of amyloid β-protein folding and oligomerization. PNAS 101: 17345–17350. PubMed PMC

Shafrir Y, Durell SR, Anishkin A, Guy HR (2010) Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils. Proteins 78: 3458–3472. PubMed PMC

Zidar J, Merzel F (2011) Probing amyloid-beta fibril stability by increasing ionic strengths. J. Phys. Chem. B 115: 2075–2081. PubMed